Sonnet BioTherapeutics, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Subsequent Events (Details Narrative)

Subsequent Events (Details Narrative) (USD $)	0 Months Ended	1 Months Ended		12 Months Ended	0 Months Ended		1 Months Ended	0 Months Ended	1 Months Ended
Subsequent Events (Details Narrative) (USD $)	Mar. 19, 2014	Apr. 30, 2014	Mar. 31, 2014	Dec. 31, 2014	Mar. 13, 2015	Mar. 16, 2015	Jan. 31, 2015	Mar. 15, 2015	Feb. 28, 2015	Nov. 30, 2014	Oct. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Dec. 31, 2013	Mar. 31, 2015
Notes team		10 years	5 years
Proceeds from issuance of convertible debt	$ 500,000us-gaap_ProceedsFromConvertibleDebt			$ 2,200,000us-gaap_ProceedsFromConvertibleDebt
Class of warrant or right, warrant exercise price	$ 5.25			$ 3.50						$ 3.50	$ 5.50	$ 3.50	$ 3.50
Common stock, par value				$ 0.0001										$ 0.0001
Minimum [Member]
Class of warrant or right, warrant exercise price											$ 2.00
Maximum [Member]
Class of warrant or right, warrant exercise price											$ 7.00
Subsequent Event [Member]
Accrued interest							250,000
Convert accrued interest to common stock							168,713
Number of units sold to private offering							$ 20
Proceeds from convertible debt and warrants							1,000,000
Debt conversion percentage							8.00%
Convertible promissory note face value					1,000,000		50,000
Warrant to purchase of common stock					320,000		12,500
Percentage of perpetuity of monthly net income					50.00%
Percentage of sales proceeds					60.00%
Notes team							3 years
Debt conversion description							The note may be voluntarily converted by the holder into shares of common stock during the period commencing 180 days after the issuance of the notes at an exercise price equal to the lesser of $2.00 per share and a 15% discount to the average of the lowest 3 trading prices for the Companys common stock during the 10 trading day period ending on the last complete trading day prior to the conversion date of the note, provided however that the conversion price shall not be less than $1.00 per share. The Warrants have an exercise price of $2.50 per share and a term of five years. In conjunction with the sale of the units, the Company also entered into a registration rights agreement pursuant to which the Company agreed to register the shares of common stock underlying the notes and warrants.
Warrant term					5 years
Class of warrant or right, warrant exercise price					$ 2.50
Number of common stock issued for subscriptions						3,899,742
Proceeds from receiving subscriptions						7,799,484
Subsequent Event [Member] \| BGR The Burger Joint [Member]
Punchase price consisting cash								4,000,000
Number of shares to contractual working capital adjustment								500,000
Subsequent Event [Member] \| BGR The Burger Joint [Member] \| Minimum [Member]
Working capital adjustment to increase cash								200,000
Subsequent Event [Member] \| BGR The Burger Joint [Member] \| Maximum [Member]
Working capital adjustment to increase cash								250,000
Subsequent Event [Member] \| BT Burger Joint [Member]
Common stock, par value															$ 0.0001
Subsequent Event [Member] \| Convertible Debt One [Member]
Accrued interest									500,000
Convert accrued interest to common stock									373,333
Subsequent Event [Member] \| Convertible Debt Two [Member]
Accrued interest									100,000
Convert accrued interest to common stock									100,000
Subsequent Event [Member] \| Two Investors [Member]
Number of warrants issued during period							250,000
Debt conversion percentage							8.00%
Warrant to purchase of common stock							37,500
Proceeds from issuance of convertible debt							$ 150,000
Common stock price per share							$ 2.50